Moreover, RRM1 predicted poor survival in GC patients without adjuvant chemotherapy (HR = 1.79; 95% CI 1.20–2.70) but failed to predict outcomes in patients who received adjuvant chemotherapy. This evidence concerns the gene RRM1 and gastric cancer.